As a matter of public policy, it sounds like it is an unintended consequence of what my colleagues, before I got here, were trying to do.

I think it may be something that we can look into in a bi-partisan way of whatever needs to be done to keep this research moving forward.

This change reflects our belief that veterans should not be denied disability compensation or access to VA health care because their symptoms may vary.

I am very concerned about a fixed date of December 31st, 2016.

Thank you very much, Chairman Coffman, and Chairman Abraham, and Ranking Member Titus, for holding this hearing on Gulf War veterans.

We have created these boxes where you start checking and it creates a problem.

I am concerned about this decision of IOM to recommend not researching it and it sounds as though the panel might have been skewed toward, this is all in your head, which is not where we are coming from.

And I do want to acknowledge the improvement that is being made, and, you know, we want to work with you to make sure that we are serving our veterans.

You know, this is a big issue. I do not need to remind anyone in the audience from New Hampshire this now polls as the number one issue in New Hampshire for voters and constituents in terms of their concern above even the economy and jobs.

The Granite State spends only $8 per capita on treatment for substance abuse.

We have got to do better.

In New Hampshire alone, we had last year 420 opioid related deaths, up from 326 the year before.